Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cgmp Regulations
Manufacturing
FDA slaps Aurobindo with warning letter on API testing failures
The FDA slapped Aurobindo Pharma with a warning letter for failing to adequately investigate batch failures of APIs and inadequate evaluations.
Joseph Keenan
Jan 27, 2022 10:50am
FDA hammers another Aurobindo plant for flawed data integrity
Jun 12, 2019 10:11am
Fosun Pharma accused of ‘massively’ faking production data
Aug 31, 2018 11:03am
Regulators again pull EuropharmaDK’s manufacturing authorization
Nov 8, 2017 11:45am
FDA hits China’s Foshan Flying Medical with warning letter
Aug 17, 2017 8:15am
China facility of Ausmetics hit with FDA warning letter
Feb 15, 2017 2:51pm